Glenmark Pharmaceuticals Inc., USA launches Clindamycin Phosphate Foam, 1%
Press Releases
Glenmark Pharmaceuticals Ltd  
February 13, 2025

Glenmark Pharmaceuticals Inc., USA launches Clindamycin Phosphate Foam, 1%

MAHWAH, N.J., Feb. 13, 2025 /PRNewswire/ -- Glenmark Pharmaceuticals Inc., USA (Glenmark) announces the launch1 of Clindamycin Phosphate Foam, 1%. Glenmark's Clindamycin Phosphate Foam, 1% is bioequivalent and therapeutically equivalent

avatar profile Olean Times Herald

Olean Times Herald


Local & Social